You are here

ARDS

Bayer ends respiratory distress drug development in latest phase 2 cleanout

Fierce Pharma

Tue, 08/8/23 - 10:21 am

adrenomedullin pegol

FDA rejects Covid-19 drug over uncertainties around small trial

Endpoints

Fri, 03/3/23 - 10:07 am

clinical trials

Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial

TheStreet.com

Sun, 03/21/21 - 11:57 pm

clinical trials

Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS

BioSpace

Fri, 11/20/20 - 11:08 am

clinical trials

Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier

BioSpace

Tue, 09/15/20 - 11:34 pm

FDA accepts Enzychem’s IND for trial of Covid-19 treatment candidate

Pharmaceutical Business Review

Fri, 08/14/20 - 09:43 am

Enzychem Lifesciences

COVID-19 pneumonia

Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon

Forbes

Sat, 05/2/20 - 11:16 pm

clinical gtrials

Preliminary Data from Pluristem’s PLC Cell Program Shows Promise in COVID-19

BioSpace

Thu, 04/9/20 - 11:29 pm

Pluristem Therapeutics

PLC cell program

Citius, Novellus collaborate on novel stem-cell therapy for ARDS associated with COVID-19

Pharmaceutical Business Review

Thu, 04/2/20 - 10:40 am

Citius Pharmaceuticals

Here's Why Athersys Is Soaring Today

Motley Fool

Tue, 04/23/19 - 11:01 pm

clinical trials

Faron Pharmaceuticals Drug Traumakine Fails Ph III Trial

CP Wire

Tue, 05/8/18 - 08:16 pm

Faron Pharmaceuticals

clinical trials

Why Questcor's Latest Clinical Study is a Big Deal

Motley Fool

Wed, 10/23/13 - 09:41 am

H.P. Acthar Gel